RASAL3 inhibitors refer to a class of chemical compounds designed to target and modulate the activity of the Ras GTPase-activating-like protein 3 (RASAL3). RASAL3 is a member of the Ras GTPase-activating protein (RasGAP) family, which plays a crucial role in the regulation of intracellular signaling pathways involved in cell growth, proliferation, and differentiation. These proteins are particularly known for their involvement in the regulation of the Ras protein family, which serves as key molecular switches in many cellular processes. RASAL3, as a member of this family, exerts its function by promoting the hydrolysis of GTP (guanosine triphosphate) to GDP (guanosine diphosphate) on Ras proteins, thereby inactivating them.
Inhibitors of RASAL3 are valuable tools in research aimed at understanding the intricate signaling networks that govern cellular responses. By modulating the activity of RASAL3, these inhibitors can provide insights into the specific roles of RASAL3 and its downstream signaling targets. This knowledge is essential for unraveling the complexity of cellular processes and may have implications in various fields, including cancer biology, where Ras proteins are frequently dysregulated. Additionally, the development of RASAL3 inhibitors contributes to advancing our understanding of the broader Ras signaling pathway and its significance in health and disease. These compounds represent a vital area of research in molecular biology and signal transduction studies, offering potential applications in unraveling the intricacies of cellular signaling mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Binds to DNA and inhibits RNA polymerase movement, potentially reducing RASAL3 mRNA synthesis. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
Specifically inhibits RNA polymerase II, potentially leading to decreased transcription of RASAL3. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Known to intercalate into DNA and RNA, which can alter gene expression and might affect RASAL3 levels. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A cytidine analog that can be incorporated into DNA and RNA, potentially disrupting RASAL3 gene expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Inhibits DNA topoisomerase I, potentially leading to decreased transcription of RASAL3. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
Inhibits RNA polymerase II transcriptional elongation, possibly affecting RASAL3 mRNA levels. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Inhibits cyclin-dependent kinases and can affect transcription, potentially reducing RASAL3 expression. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $99.00 | 5 | |
Can terminate the elongation phase of mRNA synthesis, potentially decreasing RASAL3 mRNA levels. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $65.00 $99.00 $140.00 | 85 | |
Crosslinks DNA, which can inhibit RNA synthesis and potentially affect RASAL3 transcription. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $270.00 $465.00 $1607.00 $2448.00 $5239.00 | 4 | |
Inhibits translation, which could reduce RASAL3 protein levels indirectly. |